Exploration of Targeted Anti-tumor Therapy

Open Access Review

New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme

Manisha Singh ... Rachana

Published: December 30, 2022 Explor Target Antitumor Ther. 2022;3:866–888

DOI: https://doi.org/10.37349/etat.2022.00118

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

2885 67 1

Open Access Original Article

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

Flora Doffe ... Pierre Savagner

Published: December 29, 2022 Explor Target Antitumor Ther. 2022;3:853–865

DOI: https://doi.org/10.37349/etat.2022.00117

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

3476 122 2

Open Access Commentary

De novo cholesterol biosynthesis: an additional therapeutic target for the treatment of postmenopausal breast cancer with excessive adipose tissue

Danila Coradini

Published: December 28, 2022 Explor Target Antitumor Ther. 2022;3:841–852

DOI: https://doi.org/10.37349/etat.2022.00116

Full Text PDF

2101 27 4

Open Access Original Article

Dendritic cell-targeting chemokines inhibit colorectal cancer progression

Pengkun Yuan ... Bin Ma

Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:828–840

DOI: https://doi.org/10.37349/etat.2022.00115

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

2666 32 6

Open Access Perspective

Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma

Sayuri Yoshikawa ... Satoru Matsuda

Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:817–827

DOI: https://doi.org/10.37349/etat.2022.00114

This article belongs to the special issue Theranostic Frontiers in Neuro-Oncology

Full Text PDF

5184 1746 8

Open Access Review

Artificial intelligence in breast cancer imaging: risk stratification, lesion detection and classification, treatment planning and prognosis—a narrative review

Maurizio Cè ... Michaela Cellina

Published: December 27, 2022 Explor Target Antitumor Ther. 2022;3:795–816

DOI: https://doi.org/10.37349/etat.2022.00113

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

5155 100 17

Open Access Review

Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences

Marilia Barreca ... Francesco Bertoni

Published: December 26, 2022 Explor Target Antitumor Ther. 2022;3:763–794

DOI: https://doi.org/10.37349/etat.2022.00112

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

4389 77 19

Open Access Review

Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises

Mohamad Omar Ashi ... Stéphanie Corgnac

Published: December 22, 2022 Explor Target Antitumor Ther. 2022;3:746–762

DOI: https://doi.org/10.37349/etat.2022.00111

This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment

Full Text PDF

3253 69 1

Open Access Systematic Review

Diffusion-weighted imaging and apparent diffusion coefficient mapping of head and neck lymph node metastasis: a systematic review

Maria Paola Belfiore ... Salvatore Cappabianca

Published: December 13, 2022 Explor Target Antitumor Ther. 2022;3:734–745

DOI: https://doi.org/10.37349/etat.2022.00110

This article belongs to the special issue Artificial Intelligence for Precision Oncology

Full Text PDF

4292 43 4